Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

BACKGROUND: The stimulant prodrug lisdexamfetamine dimesylate (LDX) is an effective and generally well tolerated treatment for the symptoms of attention-deficit/hyperactivity disorder (ADHD). Positive impacts of LDX on health-related quality of life and functional impairment have previously been dem...

Descripción completa

Detalles Bibliográficos
Autores principales: Banaschewski, Tobias, Johnson, Mats, Lecendreux, Michel, Zuddas, Alessandro, Adeyi, Ben, Hodgkins, Paul, Squires, Liza A., Coghill, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246127/
https://www.ncbi.nlm.nih.gov/pubmed/25139785
http://dx.doi.org/10.1007/s40263-014-0193-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246127/
https://www.ncbi.nlm.nih.gov/pubmed/25139785
http://dx.doi.org/10.1007/s40263-014-0193-z

Ejemplares similares